In May of 2023, there was a massive advance in the world of organ transplantation: the first whole human eye and partial face transplant. The man at the center of this procedure is 46-year-old Aaron James, who sustained significant facial injuries from a high-voltage work accident.
At the time, it was unclear just how successful the operation would be. Previous tests in animals had resulted in shrinkage of the transplanted eye, if not outright rejection. But now, more than a year after the transplant, a new paper in the journal JAMA outlines the success of this first-of-its-kind operation. While James cannot see out of his new eye, there is blood flow, normal pressure, and a retinal response to light.
Guest host Kathleen Davis speaks with Dr. Daniel Ceradini, director of research at NYU Langone’s Department of Plastic Surgery and first author of the JAMA study. They discuss the implications this success could have for the future of eye surgery, and the dramatic improvements in James’ quality of life.
Further Reading
- Read about the innovations that made the first whole-eye transplant possible via Nature.
Segment Guests
David Ceradini
Dr. David Ceradini is the Director of Research in NYU Langone’s Department of Plastic Surgery in New York, New York.
Segment Transcript
The transcript of this segment is being processed. It will be available within one week after the show airs.
Meet the Producer
About Kathleen Davis
@katjacquelineKathleen Davis is a producer at Science Friday, which means she spends the week brainstorming, researching, and writing, typically in that order. She’s a big fan of stories related to strange animal facts and dystopian technology.